Pharma stock jumps after receiving approval from China’s NMPA for Tacrolimus capsules
One of the pharmaceutical stocks engaged in the manufacturing of biotechnology products and research services. The stock is in focus after receiving approval from China’s National Medical Products Administration (NMPA) for Tacrolimus capsules Stock Price Movement In Friday’s trading session, Biocon Limited’s share jumped to an intraday high of 1.18 percent from the previous close … Continue reading Pharma stock jumps after receiving approval from China’s NMPA for Tacrolimus capsules
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed